CD93 Antibodies

Santa Cruz Biotechnology features a diverse variety of CD93 monoclonal antibodies for investigating CD93's role in various biological processes. CD93 monoclonal antibodies are validated for multiple applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD93, also known as the activation-induced C-type lectin (AICL), plays a critical role in immune responses and cell adhesion. CD93 is involved in the regulation of monocyte and macrophage functions, influencing inflammation and tissue repair. Understanding CD93 function is essential for elucidating potential implications in various diseases, including cancer and autoimmune disorders. Researchers can explore CD93's expression patterns across different cell types and tissues to better understand its biological functions. CD93 monoclonal antibodies enable detailed analysis of protein localization and interactions within cellular pathways. CD93 research continues to reveal new insights into immune system regulation and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies for CD93 support researchers worldwide in advancing scientific understanding of immune system biology and disease pathways.